The Ensign Group, Inc.
General ticker "ENSG" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $9.8B (TTM average)
The Ensign Group, Inc. follows the US Stock Market performance with the rate: 47.0%.
Estimated limits based on current volatility of 1.9%: low 182.54$, high 189.65$
Factors to consider:
- Earnings expected soon, date: 2026-05-05 amc
- Company pays dividends (quarterly): last record date 2026-03-31, amount 0.07$ (Y0.15%)
- Total employees count: 39300 (+11.3%) as of 2024
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Healthcare policy changes, Political conditions, Government audits, Acquisition/divestiture risks, Insurance risks
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [149.52$, 206.23$]
- 2026-12-31 to 2027-12-31 estimated range: [159.51$, 219.36$]
Financial Metrics affecting the ENSG estimates:
- Negative: with PPE of 27.0 at the end of fiscal year the price was high
- Positive: 7.68 < Operating profit margin, % of 8.58
- Positive: 0.07 < Operating cash flow per share per price, % of 5.55
- Positive: 19.49 < Shareholder equity ratio, % of 40.85 <= 42.60
- Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 5.93
- Positive: 5.46 < Industry operating cash flow per share per price (median), % of 5.62
- Positive: -14.24 < Investing cash flow per share per price, % of -5.05
- Negative: 0.01 < Interest expense per share per price, % of 0.08
Short-term ENSG quotes
Long-term ENSG plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $3,729.36MM | $4,260.48MM | $5,057.84MM |
| Operating Expenses | $3,473.99MM | $3,902.18MM | $4,624.05MM |
| Operating Income | $255.37MM | $358.30MM | $433.80MM |
| Non-Operating Income | $17.39MM | $27.79MM | $21.83MM |
| Interest Expense | $8.09MM | $8.29MM | $7.99MM |
| Income(Loss) | $272.76MM | $386.09MM | $455.62MM |
| Taxes | $62.91MM | $87.64MM | $111.36MM |
| Profit(Loss)* | $209.40MM | $297.97MM | $343.97MM |
| Stockholders Equity | $1,491.87MM | $1,837.11MM | $2,231.72MM |
| Assets | $4,177.54MM | $4,669.36MM | $5,462.97MM |
| Operating Cash Flow | $376.67MM | $347.19MM | $564.27MM |
| Capital expenditure | $106.18MM | $158.24MM | $193.56MM |
| Investing Cash Flow | $-182.70MM | $-390.05MM | $-513.18MM |
| Financing Cash Flow | $-0.61MM | $-2.16MM | $-11.81MM |
| Earnings Per Share** | $3.76 | $5.26 | $6.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.